Brevan Howard Capital Management LP Charles River Laboratories International, Inc. Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q3 2024
A detailed history of Brevan Howard Capital Management LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 4,214 shares of CRL stock, worth $815,619. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,214
Previous 2,749
53.29%
Holding current value
$815,619
Previous $567,000
46.38%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CRL
# of Institutions
696Shares Held
52.3MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.18 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$985 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$724 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$412 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$375 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.84B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...